0001493152-23-022163.txt : 20230622
0001493152-23-022163.hdr.sgml : 20230622
20230622201733
ACCESSION NUMBER: 0001493152-23-022163
CONFORMED SUBMISSION TYPE: 4/A
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20230616
FILED AS OF DATE: 20230622
DATE AS OF CHANGE: 20230622
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: GLECKEL LOUIS MD
CENTRAL INDEX KEY: 0001164762
FILING VALUES:
FORM TYPE: 4/A
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-21617
FILM NUMBER: 231034690
MAIL ADDRESS:
STREET 1: C/O PROHEALTH CARE ASSOCIATES LLP
STREET 2: 2800 METRUS AVE
CITY: LAKE SUCCESS
STATE: NY
ZIP: 11042
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: ProPhase Labs, Inc.
CENTRAL INDEX KEY: 0000868278
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 232577138
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 711 STEWART AVE, SUITE 200
STREET 2: GARDEN CITY
CITY: NEW YORK
STATE: NY
ZIP: 11530
BUSINESS PHONE: (215) 345-0919
MAIL ADDRESS:
STREET 1: 711 STEWART AVE, SUITE 200
STREET 2: GARDEN CITY
CITY: NEW YORK
STATE: NY
ZIP: 11530
FORMER COMPANY:
FORMER CONFORMED NAME: QUIGLEY CORP
DATE OF NAME CHANGE: 19930328
4/A
1
ownership.xml
X0407
4/A
2023-06-16
2023-06-21
0
0000868278
ProPhase Labs, Inc.
PRPH
0001164762
GLECKEL LOUIS MD
711 STEWART AVE,
SUITE 200
GARDEN CITY,
NY
11530
1
0
0
0
0
Option (right to buy)
7.31
2023-06-16
4
A
0
40000
0.00
A
2030-06-15
Common Stock
40000
40000
D
The transaction reported in this row involves a grant by the Issuer to the Reporting Person of a stock option to purchase the Issuer's common stock (the "Option"), with such option vesting in four equal installments on September 30, 2023, December 31, 2023, March 31, 2024 and June 30, 2024, provided the recipient continues to serve as a non-employee director of the Issuer on each such vesting date, as detailed in a stock option award agreement by and between the Issuer and the Reporting Person, dated as of June 16, 2023.
This amended report on Form 4 is being filed to correct the Transaction Date and Expiration Date of the Option, which were inadvertently misreported in the original Form 4 filed on June 21, 2023.
/s/ Louis Gleckel MD
2023-06-22